The CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial)
Public ClinicalTrials.gov record NCT01137812. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Active-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin Versus Sitagliptin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sulphonylurea Therapy
Study identification
- NCT ID
- NCT01137812
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Janssen Research & Development, LLC
- Industry
- Enrollment
- 756 participants
Conditions and interventions
Conditions
Interventions
- Canagliflozin 300 mg Drug
- Metformin Drug
- Sitagliptin 100 mg Drug
- Sulphonylurea Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2010
- Primary completion
- Feb 29, 2012
- Completion
- Feb 29, 2012
- Last update posted
- Jan 14, 2015
2010 – 2012
United States locations
- U.S. sites
- 85
- U.S. states
- 26
- U.S. cities
- 85
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Mobile | Alabama | — | — |
| Not listed | Goodyear | Arizona | — | — |
| Not listed | Mesa | Arizona | — | — |
| Not listed | Escondido | California | — | — |
| Not listed | Fresno | California | — | — |
| Not listed | Greenbrae | California | — | — |
| Not listed | La Mesa | California | — | — |
| Not listed | Laguna Hills | California | — | — |
| Not listed | Lancaster | California | — | — |
| Not listed | Long Beach | California | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | Norwalk | California | — | — |
| Not listed | Pismo Beach | California | — | — |
| Not listed | Roseville | California | — | — |
| Not listed | Spring Valley | California | — | — |
| Not listed | Walnut Creek | California | — | — |
| Not listed | Watsonville | California | — | — |
| Not listed | Denver | Colorado | — | — |
| Not listed | Northglenn | Colorado | — | — |
| Not listed | Milford | Connecticut | — | — |
| Not listed | Bradenton | Florida | — | — |
| Not listed | Cape Coral | Florida | — | — |
| Not listed | Clearwater | Florida | — | — |
| Not listed | Delray Beach | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Pembroke Pines | Florida | — | — |
| Not listed | Tampa | Florida | — | — |
| Not listed | Atlanta | Georgia | — | — |
| Not listed | Lewiston | Idaho | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | O'Fallon | Illinois | — | — |
| Not listed | Springfield | Illinois | — | — |
| Not listed | Topeka | Kansas | — | — |
| Not listed | Bowling Green | Kentucky | — | — |
| Not listed | Lexington | Kentucky | — | — |
| Not listed | Madisonville | Kentucky | — | — |
| Not listed | Baton Rouge | Louisiana | — | — |
| Not listed | Mandeville | Louisiana | — | — |
| Not listed | Metairie | Louisiana | — | — |
| Not listed | Sunset | Louisiana | — | — |
| Not listed | Brockton | Massachusetts | — | — |
| Not listed | Saint Clair Shores | Michigan | — | — |
| Not listed | Southfield | Michigan | — | — |
| Not listed | Dakota Dunes | Nebraska | — | — |
| Not listed | Toms River | New Jersey | — | — |
| Not listed | Albuquerque | New Mexico | — | — |
| Not listed | West Seneca | New York | — | — |
| Not listed | Calabash | North Carolina | — | — |
| Not listed | Greensboro | North Carolina | — | — |
| Not listed | Moerhead City | North Carolina | — | — |
| Not listed | Morganton | North Carolina | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Gallipolis | Ohio | — | — |
| Not listed | Marion | Ohio | — | — |
| Not listed | Mason | Ohio | — | — |
| Not listed | Toledo | Ohio | — | — |
| Not listed | Zanesville | Ohio | — | — |
| Not listed | Beaver | Pennsylvania | — | — |
| Not listed | Bensalem | Pennsylvania | — | — |
| Not listed | Norristown | Pennsylvania | — | — |
| Not listed | Perryopolis | Pennsylvania | — | — |
| Not listed | Philadelphia | Pennsylvania | — | — |
| Not listed | Pittsburgh | Pennsylvania | — | — |
| Not listed | Pottstown | Pennsylvania | — | — |
| Not listed | Greenville | South Carolina | — | — |
| Not listed | Spartanburg | South Carolina | — | — |
| Not listed | Johnson City | Tennessee | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | Fort Worth | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Killeen | Texas | — | — |
| Not listed | Richardson | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Schertz | Texas | — | — |
| Not listed | Sugar Land | Texas | — | — |
| Not listed | Burke | Virginia | — | — |
| Not listed | Danville | Virginia | — | — |
| Not listed | Falls Church | Virginia | — | — |
| Not listed | Hampton | Virginia | — | — |
| Not listed | Henrico | Virginia | — | — |
| Not listed | Manassas | Virginia | — | — |
| Not listed | Norfolk | Virginia | — | — |
| Not listed | Richmond | Virginia | — | — |
| Not listed | Selah | Washington | — | — |
| Not listed | Tacoma | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 99 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01137812, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 14, 2015 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01137812 live on ClinicalTrials.gov.